ReviewBreast (Edinburgh, Scotland)2017

Evolving landscape of human epidermal growth factor receptor 2-positive breast cancer treatment and the future of biosimilars.

Christian Jackisch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.